EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 337 filers reported holding EXELIXIS INC in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $23,000 | -73.9% | 1,261 | -69.8% | 0.00% | -71.4% |
| Q3 2021 | $88,000 | +4300.0% | 4,179 | +4079.0% | 0.01% | – |
| Q4 2019 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $2,000 | -85.7% | 100 | -85.7% | 0.00% | -66.7% |
| Q4 2018 | $14,000 | +16.7% | 700 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $12,000 | +140.0% | 700 | +250.0% | 0.01% | +500.0% |
| Q3 2017 | $5,000 | -100.0% | 200 | -50.0% | 0.00% | -50.0% |
| Q2 2017 | $10,000,000 | +11.1% | 400 | 0.0% | 0.00% | -33.3% |
| Q1 2017 | $9,000,000 | +50.0% | 400 | 0.0% | 0.00% | +200.0% |
| Q4 2016 | $6,000,000 | +74900.0% | 400 | -33.3% | 0.00% | 0.0% |
| Q3 2016 | $8,000 | +14.3% | 600 | -40.0% | 0.00% | -50.0% |
| Q2 2016 | $7,000 | +75.0% | 1,000 | 0.0% | 0.00% | +100.0% |
| Q1 2016 | $4,000 | -20.0% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $5,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $5,000 | +66.7% | 1,000 | 0.0% | 0.00% | +100.0% |
| Q2 2015 | $3,000 | +50.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $2,000 | +100.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2014 | $1,000 | -50.0% | 1,000 | -16.7% | 0.00% | – |
| Q3 2014 | $2,000 | -84.6% | 1,200 | -62.5% | 0.00% | -100.0% |
| Q2 2014 | $13,000 | – | 3,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,966,038 | $282,918,000 | 60.81% |
| NEXTHERA CAPITAL LP | 1,735,030 | $30,745,000 | 5.89% |
| GREAT POINT PARTNERS LLC | 2,075,000 | $36,769,000 | 5.73% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 704,534 | $9,574,000 | 4.55% |
| Matrix Capital Management Company, LP | 10,000,000 | $177,200,000 | 4.38% |
| Consonance Capital Management LP | 3,879,050 | $68,737,000 | 3.70% |
| Rhenman & Partners Asset Management AB | 1,261,414 | $22,352,000 | 2.24% |
| BB BIOTECH AG | 2,785,000 | $49,350,000 | 1.31% |
| CAPITAL MANAGEMENT CORP /VA | 285,575 | $5,060,000 | 1.29% |
| TEALWOOD ASSET MANAGEMENT INC | 155,376 | $2,753,000 | 1.03% |